< Back to previous page
Patent
Elimination of immune responses to viral vectors
The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from a viral vector antigen and a redox motif such as C-(X)2-[CST] or [CST]-(X)2-C in the prevention and/or suppression of immune responses to viral vectors and in the manufacture of medicaments therefore.
Patent Publication Number: US9044507
Year filing: 2009
Year approval: 2015
Year publication: 2015
Status: Assigned
URI: link to Espacenet
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven